Reviews Baygam


No reviews yet.

Baygam Drug Description
BayGam™
Immune Globulin (Human)
Solvent/Detergent Treated
DRUG DESCRIPTION
Immune Globulin (Human) — BayGam™ treated with solvent/detergent is a
sterile solution of immune globulin for intramuscular administration; it contains
no preservative. BayGam is prepared by cold ethanol fractionation from human
plasma. The immune globulin is isolated from solubilized Cohn fraction II. The
fraction II solution is adjusted to a final concentration of 0.3% tri-n-butyl
phosphate (TNBP) and 0.2% sodium cholate. After the addition of solvent (TNBP)
and detergent (sodium cholate), the solution is heated to 30°C and maintained
at that temperature for not less than 6 hours. After the viral inactivation
step, the reactants are removed by precipitation, filtration and finally ultrafiltration
and diafiltra-tion. BayGam is formulated as a 15–18% protein solution at a pH
of 6.4–7.2 in 0.21–0.32 M glycine. BayGam is then incubated in the final container
for 21–28 days at 20–27°C.
The removal and inactivation of spiked model enveloped and non-enveloped viruses
during the manufacturing process for BayGam has been validated in laboratory
studies. Human Immunodeficiency Virus, Type 1 (HIV-1), was chosen as the relevant
virus for blood products; Bovine Viral Diarrhea Virus (BVDV) was chosen to model
Hepatitis C virus; Pseudorabies virus (PRV) was chosen to model Hepatitis B
virus and the Herpes viruses; and Reo virus type 3 (Reo) was chosen to model
non-enveloped viruses and for its resistance to physical and chemical inactivation.
Significant removal of model enveloped and non-enveloped viruses is achieved
at two steps in the Cohn fractionation process leading to the collection of
Cohn Fraction II:the precipitation and removal of Fraction III in the processing
of Fraction II + IIIW suspension to Effluent IIIand the filtration step in the
processing of Effluent III to Filtrate III. Significant inactivation of enveloped
viruses is achieved at the time of treatment of solubilized Cohn Fraction II
with TNBP/sodium cholate.Last reviewed on RxList: 11/13/2008




Baygam Drug Description
BayGam™
Immune Globulin (Human)
Solvent/Detergent Treated
DRUG DESCRIPTION
Immune Globulin (Human) — BayGam™ treated with solvent/detergent is a
sterile solution of immune globulin for intramuscular administration; it contains
no preservative. BayGam is prepared by cold ethanol fractionation from human
plasma. The immune globulin is isolated from solubilized Cohn fraction II. The
fraction II solution is adjusted to a final concentration of 0.3% tri-n-butyl
phosphate (TNBP) and 0.2% sodium cholate. After the addition of solvent (TNBP)
and detergent (sodium cholate), the solution is heated to 30°C and maintained
at that temperature for not less than 6 hours. After the viral inactivation
step, the reactants are removed by precipitation, filtration and finally ultrafiltration
and diafiltra-tion. BayGam is formulated as a 15–18% protein solution at a pH
of 6.4–7.2 in 0.21–0.32 M glycine. BayGam is then incubated in the final container
for 21–28 days at 20–27°C.
The removal and inactivation of spiked model enveloped and non-enveloped viruses
during the manufacturing process for BayGam has been validated in laboratory
studies. Human Immunodeficiency Virus, Type 1 (HIV-1), was chosen as the relevant
virus for blood products; Bovine Viral Diarrhea Virus (BVDV) was chosen to model
Hepatitis C virus; Pseudorabies virus (PRV) was chosen to model Hepatitis B
virus and the Herpes viruses; and Reo virus type 3 (Reo) was chosen to model
non-enveloped viruses and for its resistance to physical and chemical inactivation.
Significant removal of model enveloped and non-enveloped viruses is achieved
at two steps in the Cohn fractionation process leading to the collection of
Cohn Fraction II:the precipitation and removal of Fraction III in the processing
of Fraction II + IIIW suspension to Effluent IIIand the filtration step in the
processing of Effluent III to Filtrate III. Significant inactivation of enveloped
viruses is achieved at the time of treatment of solubilized Cohn Fraction II
with TNBP/sodium cholate.Last reviewed on RxList: 11/13/2008




Baygam Drug Description
BayGam™
Immune Globulin (Human)
Solvent/Detergent Treated
DRUG DESCRIPTION
Immune Globulin (Human) — BayGam™ treated with solvent/detergent is a
sterile solution of immune globulin for intramuscular administration; it contains
no preservative. BayGam is prepared by cold ethanol fractionation from human
plasma. The immune globulin is isolated from solubilized Cohn fraction II. The
fraction II solution is adjusted to a final concentration of 0.3% tri-n-butyl
phosphate (TNBP) and 0.2% sodium cholate. After the addition of solvent (TNBP)
and detergent (sodium cholate), the solution is heated to 30°C and maintained
at that temperature for not less than 6 hours. After the viral inactivation
step, the reactants are removed by precipitation, filtration and finally ultrafiltration
and diafiltra-tion. BayGam is formulated as a 15–18% protein solution at a pH
of 6.4–7.2 in 0.21–0.32 M glycine. BayGam is then incubated in the final container
for 21–28 days at 20–27°C.
The removal and inactivation of spiked model enveloped and non-enveloped viruses
during the manufacturing process for BayGam has been validated in laboratory
studies. Human Immunodeficiency Virus, Type 1 (HIV-1), was chosen as the relevant
virus for blood products; Bovine Viral Diarrhea Virus (BVDV) was chosen to model
Hepatitis C virus; Pseudorabies virus (PRV) was chosen to model Hepatitis B
virus and the Herpes viruses; and Reo virus type 3 (Reo) was chosen to model
non-enveloped viruses and for its resistance to physical and chemical inactivation.
Significant removal of model enveloped and non-enveloped viruses is achieved
at two steps in the Cohn fractionation process leading to the collection of
Cohn Fraction II:the precipitation and removal of Fraction III in the processing
of Fraction II + IIIW suspension to Effluent IIIand the filtration step in the
processing of Effluent III to Filtrate III. Significant inactivation of enveloped
viruses is achieved at the time of treatment of solubilized Cohn Fraction II
with TNBP/sodium cholate.Last reviewed on RxList: 11/13/2008




Baygam Drug Description
BayGam™
Immune Globulin (Human)
Solvent/Detergent Treated
DRUG DESCRIPTION
Immune Globulin (Human) — BayGam™ treated with solvent/detergent is a
sterile solution of immune globulin for intramuscular administration; it contains
no preservative. BayGam is prepared by cold ethanol fractionation from human
plasma. The immune globulin is isolated from solubilized Cohn fraction II. The
fraction II solution is adjusted to a final concentration of 0.3% tri-n-butyl
phosphate (TNBP) and 0.2% sodium cholate. After the addition of solvent (TNBP)
and detergent (sodium cholate), the solution is heated to 30°C and maintained
at that temperature for not less than 6 hours. After the viral inactivation
step, the reactants are removed by precipitation, filtration and finally ultrafiltration
and diafiltra-tion. BayGam is formulated as a 15–18% protein solution at a pH
of 6.4–7.2 in 0.21–0.32 M glycine. BayGam is then incubated in the final container
for 21–28 days at 20–27°C.
The removal and inactivation of spiked model enveloped and non-enveloped viruses
during the manufacturing process for BayGam has been validated in laboratory
studies. Human Immunodeficiency Virus, Type 1 (HIV-1), was chosen as the relevant
virus for blood products; Bovine Viral Diarrhea Virus (BVDV) was chosen to model
Hepatitis C virus; Pseudorabies virus (PRV) was chosen to model Hepatitis B
virus and the Herpes viruses; and Reo virus type 3 (Reo) was chosen to model
non-enveloped viruses and for its resistance to physical and chemical inactivation.
Significant removal of model enveloped and non-enveloped viruses is achieved
at two steps in the Cohn fractionation process leading to the collection of
Cohn Fraction II:the precipitation and removal of Fraction III in the processing
of Fraction II + IIIW suspension to Effluent IIIand the filtration step in the
processing of Effluent III to Filtrate III. Significant inactivation of enveloped
viruses is achieved at the time of treatment of solubilized Cohn Fraction II
with TNBP/sodium cholate.Last reviewed on RxList: 11/13/2008




Baygam Drug Description
BayGam™
Immune Globulin (Human)
Solvent/Detergent Treated
DRUG DESCRIPTION
Immune Globulin (Human) — BayGam™ treated with solvent/detergent is a
sterile solution of immune globulin for intramuscular administration; it contains
no preservative. BayGam is prepared by cold ethanol fractionation from human
plasma. The immune globulin is isolated from solubilized Cohn fraction II. The
fraction II solution is adjusted to a final concentration of 0.3% tri-n-butyl
phosphate (TNBP) and 0.2% sodium cholate. After the addition of solvent (TNBP)
and detergent (sodium cholate), the solution is heated to 30°C and maintained
at that temperature for not less than 6 hours. After the viral inactivation
step, the reactants are removed by precipitation, filtration and finally ultrafiltration
and diafiltra-tion. BayGam is formulated as a 15–18% protein solution at a pH
of 6.4–7.2 in 0.21–0.32 M glycine. BayGam is then incubated in the final container
for 21–28 days at 20–27°C.
The removal and inactivation of spiked model enveloped and non-enveloped viruses
during the manufacturing process for BayGam has been validated in laboratory
studies. Human Immunodeficiency Virus, Type 1 (HIV-1), was chosen as the relevant
virus for blood products; Bovine Viral Diarrhea Virus (BVDV) was chosen to model
Hepatitis C virus; Pseudorabies virus (PRV) was chosen to model Hepatitis B
virus and the Herpes viruses; and Reo virus type 3 (Reo) was chosen to model
non-enveloped viruses and for its resistance to physical and chemical inactivation.
Significant removal of model enveloped and non-enveloped viruses is achieved
at two steps in the Cohn fractionation process leading to the collection of
Cohn Fraction II:the precipitation and removal of Fraction III in the processing
of Fraction II + IIIW suspension to Effluent IIIand the filtration step in the
processing of Effluent III to Filtrate III. Significant inactivation of enveloped
viruses is achieved at the time of treatment of solubilized Cohn Fraction II
with TNBP/sodium cholate.Last reviewed on RxList: 11/13/2008





Other reviews about Baygam on wordpress

One of the more common causes of acute hepatitis i …
  by clinicalpediatric
One of the more common causes of acute hepatitis is hepatitis A virus (HAV). The hepatitis A virus was isolated by Purcell in 1973. Since the application of […]


Teachings
  by ravidassia
baygam puraa sahar ko naa-o. Baygumpura, 'the city without sorrow', is the name of the town. dookh andohu nahee tihi thaa-o. There is no suffering or anxiety there. naaN tasvees khiraaj […]



Other reviews about Baygam on web:

Learn about the prescription medication Baygam (Immune Globulin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Baygam (Immune Globulin) Drug Information: Uses, Side Effects ...


All about BayGam. View complete and up to date BayGam information - part of the Drugs.com trusted medication database. BayGam Facts and Comparisons at Drugs.com


Learn more about Baygam. Find the Web's best health guides, medical reports, news, videos and tools for Baygam. Share Baygam experiences and get advice from experts. Baygam Overview - References, Advice, News, Videos, Coping & Support


Baygam Read Experiences, Ask Questions and Exchange Thoughts on Baygam - 100% Free. 100% Helpful. Baygam - Ask Your Questions on Baygam - Healthsofa.com


Find patient medical information for BayGam IM on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. BayGam IM : Uses, Side Effects, Interactions, Pictures, Warnings ...


Baygam patient information. Detailed drug information for the consumer, includes dosage, Baygam side effects and more. Baygam consumer information from Drugs.com


What is Baygam (Immune Globulin Intramuscular)? Immune globulin for intramuscular administration (IGIM) is a sterilized solution obtained from pooled human blood. Baygam - Drugs & Treatments - Revolution Health


Baygam - MedHelp's Baygam Center for Information, Symptoms, Resources, Treatments and Tools for Baygam. Find Baygam information, treatments for Baygam and Baygam symptoms. Baygam - Symptoms, Treatments and Resources for Baygam


About Your Treatment. Your doctor has ordered IGIV. The drug may be given alone or added to an intravenous fluid that will drip through a needle or catheter placed in your vein for 2 ... Baygam - Kosmix : Reference, Videos, Images, News, Shopping and ...


Immune globulin for intramuscular administration (IGIM) is a sterilized solution obtained from pooled human blood. It contains the immunoglobulins (or antibodies) to protect ... Baygam Information - Drugs and Treatments - MedHelp





Featured Reviews

Reviews Bucharest Restaurants

If u are searching for Bucharest restaurants reviews, than i am suggesting you to visit www.Restograf.ro. This site has been done and maintained by George Butunoiu (www.georgebutunoiu.com), one of the biggest executive search persons here in...
Read More  |  Review This
Reviews Clonazepam

Klonopin Drug Description KLONOPIN® (clonazepam) Tablets KLONOPIN® WAFERS (clonazepam) Orally Disintegrating Tablets DRUG DESCRIPTION What are the possible side effects of clonazepam (Klonopin, Klonopin Wafer)? Get...
Read More  |  Review This
Reviews Estazolam

Prosom Drug Description ProSom™ (estazolam) Tablets DRUG DESCRIPTION What are the possible side effects of estazolam (Prosom)? Estazolam may cause a severe allergic reaction. Stop taking estazolam and get emergency medical...
Read More  |  Review This
Reviews Cystadane

Cystadane Drug Description Cystadane (betaine anhydrous) for Oral Solution Powder DRUG DESCRIPTION What are the possible side effects of betaine (Cystadane)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Mometasone Furoate Ointment

Elocon Ointment Drug Description ELOCON® (mometasone furoate) Ointment 0.1%
For Dermatologic Use Only Not for Ophthalmic Use DRUG DESCRIPTION What are the possible side effects of mometasone topical (Elocon)? Get emergency...

Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....